SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-12-001483
Filing Date
2012-03-12
Accepted
2012-03-12 15:28:57
Documents
15
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 c68781_10-k.htm 10-K 1144729
2 c68781_ex12-1.htm EX-12.1 28538
3 c68781_ex21-1.htm EX-21.1 2413
4 c68781_ex23-1.htm EX-23.1 1472
5 c68781_ex31-1.htm EX-31.1 10317
6 c68781_ex31-2.htm EX-31.2 10069
7 c68781_ex32-1.htm EX-32.1 3657
8 c68781_ex32-2.htm EX-32.2 3552
9 GRAPHIC c68781001_v1.jpg GRAPHIC 41399
  Complete submission text file 0000930413-12-001483.txt   5286158

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE enzn-20111231.xml EX-101.INS 1043051
11 enzn-20111231.xsd EX-101.SCH 26158
12 XBRL CALCULATION FILE enzn-20111231_cal.xml EX-101.CAL 31788
13 XBRL DEFINITION FILE enzn-20111231_def.xml EX-101.DEF 115850
14 XBRL LABEL FILE enzn-20111231_lab.xml EX-101.LAB 151451
15 XBRL PRESENTATION FILE enzn-20111231_pre.xml EX-101.PRE 134946
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12957 | Film No.: 12683808
SIC: 2836 Biological Products, (No Diagnostic Substances)